| 标题 |
Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer |
| 网址 | |
| DOI | |
| 其它 |
期刊:Gynecologic Oncology 作者:David M. O’Malley; Ursula A. Matulonis; Michael J. Birrer; Cesar M. Castro; Lucy Gilbert; et al 出版日期:2020-02-18 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)